Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:10 AM
Ignite Modification Date:
2025-12-25 @ 2:10 AM
NCT ID:
NCT03661060
Eligibility Criteria:
Inclusion Criteria:
* All consecutive patients with chronic HF and those admitted for acute (de novo) or worsening chronic HF.
* Chronic HF: any NYHA class (I-IV).
* Acute HF Only patients in NYHA class III or IV, or with pulmonary edema or cardiogenic shock for whom an IV therapy specific for HF (diuretic, vasodilators, vasopressors) is administered.
* Any gender.
* Any etiology of HF.
* Any level of EF.
* Written informed consent.
Exclusion Criteria:
* \- Age \<18 years.
* Inclusion in registries or trials that can influence, by protocol, the clinical management of patients.
* Patients already enrolled in the BLITZ HF (by another participating centre or in the first enrollment period).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03661060
Study Brief:
Protocol Section:
NCT03661060